絞り込み

16647

広告

Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.

著者 Danpornprasert P , Foongladda S , Tscheikuna J
J Med Assoc Thai.2010 Jan ; 93 Suppl 1():S86-93.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Division of Respiratory Disease and Tuberculosis, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

スターを付ける スターを付ける     (141view , 0users)

Medical

Invasive pulmonary aspergillosis (IPA) is an important cause of morbidity and mortality among immunocompromised patients especially in neutropenic and patients treated with immunosuppressive drugs. New diagnostic tools have been developed to improve treatment and outcome. Compared with serum galactomannan, bronchoalveolar lavage galactomannan (BAL GM) detection has higher sensitivity (81% vs. 71%) and comparable specificity (87.6% vs. 89%). No study has correlated this test result to clinical outcome.
PMID: 20364562 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード